Half Yearly Accounts -...

First 22 Last

Share
Profile

Follow
parcs

682 Posts.

7

23/03/19

19:58

Post #: 37863798
Share

Originally posted by Mr.Red: ↑

yep... fear of management is what has let this down..

not to mention:

1. over indulged fat pay packets and self proclaimed bonuses
2. bleeding shareholders forever since start up
3. basic mentality of thinking presentations will drive the SP
4. tenements that have amounted to nothing but simple documents with figures of recorded resources
5. plays on shareholders using the ASX via a consolidation and endless capital raises
6. and a MD that has got rich along the ride without having to work a hard day since Azure was started...

sad isn't it?... prove me worng

Teck know the history of this management, so SH'ers dont think for a second if they find something substantial that they are going to pay out some millions... come on they are smarter than that... I have learnt that the hard way... Teck will take it Alacran back at bargain a price.... after all what does Tony have to back him... shareholders are running for the door as seen in the SP

shareholders as usual are in trouble with this bleeder.

revenue!!!!!!!!!!!!!!........... what revenue??????????????

these prices are the lowest the SP has ever been.... surely LT's shareholders are sad and embarrassed to hold this stock, I know I am, and I'm a mid term holder..... the Germans and Creasy must be hating Tony right know and feeling some what manipulated and lied to...

long term holders posts are seemingly desperate...

Expand

Half Yearly Accounts - https://www.asx.com.au/asxpdf/20190227/pdf/4431b9t7jhrrw2.pdf

$80.7M in issued capital
$73.3M in accumulated losses

Nuff said...

AZS Price at posting: 10.5¢ Sentiment: None Disclosure: Not Held
6 Upvote

0 Great analysis

Reply

Top Stories

RBL

Recce scores $6.75M R&D rebate

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HUM

Auric sniffs gold up to 12.1g/t through drilling at Spargoville prospects

TYX

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

There are more pages in this discussion • 3 more messages in this thread...

First 22 Last

Add AZS (ASX) to my watchlist

Half Yearly Accounts -...

Top Stories

Recce scores $6.75M R&D rebate

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Cyclone signs MOU with Vale for development of Iron Bear play

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Auric sniffs gold up to 12.1g/t through drilling at Spargoville prospects

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch